Horizon Therapeutics' (HZNP) Tepezza Sales Rebound in April, Commentary from the Jefferies Healthcare Conference
Go back to Horizon Therapeutics' (HZNP) Tepezza Sales Rebound in April, Commentary from the Jefferies Healthcare ConferenceHORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $116.30 | 52 Week High | $23.44 | |||
Open | $116.30 | 52 Week Low | $13.06 | |||
Day High | $116.30 | P/E | N/A | |||
Day Low | $116.30 | EPS | $-0.96 | |||
Volume | 2,566 |